Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
There is a brand new research report just out about the estimates of over $1 billion a year revenue for the Massachusetts medical and adult use cannabis market.
Anyone that really wants to understand this market and the potential impact on AmeriCann and their big project in Freetown should spend the $50 and download and read it. ( New Frontier-Arcview-Massachusetts report)
NEW REPORT: Massachusetts Marijuana Sales to Top $1 Billion by 2020
Marketwired MarketwiredDec 21, 2016, 6:00 AM
OAKLAND, CA--(Marketwired - December 21, 2016) - Arcview Market Research, the leading publisher of cannabis market research, in partnership with New Frontier Data, the cannabis Big Data and analytics authority has released its Massachusetts Legal Cannabis Market State Profile, which shows the potential growth of the legal marijuana market after Massachusetts voters legalized adult-use on Election Night 2016. The official Arcview Market Research projection for the Massachusetts market is that it will grow to over $1 billion by 2020 at a compound annual growth rate of 113%.
"Unlike other places where cannabis is legal, Boston is within driving distance of many of the most populous places in America. This will make Boston the cannabis capital of the world in short order. This cannabis tourism will drive significant revenue, tax dollars, and job growth which will make legalization very attractive to neighboring states," said Troy Dayton, CEO of The Arcview Group.
Mass MJ market is exploding with growth and ACAN is right in the middle of the state with approval for 25 football fields of cannabis cultivation zoned and ready to build in early 2017.
The value to ACAN could be massive and they and their contractor Campanelli can replicate this project in other states.
This company is trading way below many other cannabis stocks with far less and is about to get discovered by investors.
2017 could be a real exciting year for ACAN stockholders.
Great update this morning on ACAN...
AmeriCann Engages Campanelli Construction to Build Massachusetts Medical Cannabis Center
Accesswire AccesswireDecember 20, 2016Comment
Finalizing Design Plans for One of the Largest and Most Technologically Advanced Cannabis Cultivation Facilities in the Nation
Plans to Break Ground on the First Phase in the First Quarter of 2017
DENVER, CO / ACCESSWIRE / December 20, 2016 / AmeriCann, Inc. (ACAN), a company that is developing sustainable, state-of-the-art medical cannabis cultivation properties, has retained Campanelli Construction as the General Contractor for the Massachusetts Medical Cannabis Center (the "MMCC").
Campanelli is a third generation, full-service commercial real estate development and acquisition company. The company has over six decades of successful experience having developed, built and acquired over 22 million square feet of property. Campanelli has set a precedent for executing multi-market development of highly specialized real estate, providing design-build services for clients throughout the country.
AmeriCann plans to develop the property as the Massachusetts Medical Cannabis Center, one of the largest and most technologically advanced cannabis cultivation facilities in the nation. Designs for the MMCC include the construction of sustainable greenhouse cultivation, processing, and infused product facilities that will be leased or sold to Registered Marijuana Dispensaries under the Massachusetts Medical Marijuana Program. AmeriCann's Cannopy System uniquely combines expertise from traditional horticulture, lean manufacturing, regulatory compliance and cannabis cultivation to create superior facilities and procedures.
"Campanelli proved to be an invaluable resource for our project in Massachusetts. We are confident in having such a knowledgeable local partner with national expertise and look forward to replicating this success by working with Campanelli on future projects throughout the nation," stated AmeriCann CEO Tim Keogh. Campanelli provided AmeriCann with its vertically-integrated real estate services including brokerage, development and construction management.
AmeriCann acquired the rights to the 53-acre property in Freetown earlier this year. The sustainable greenhouse project will consist of multiple planned phases; the first phase will include two buildings at 130,000 and 30,000 square feet, respectively. Future phases are permitted for an additional 800,000+ square feet based on market demand.
AmeriCann plans to break ground on the first phase in the first quarter of 2017 and AmeriCann's Preferred Partners will have cannabis in production on the property by fall of 2017.
"Campanelli has a long history of constructing institutional grade commercial and industrial real estate throughout the nation. The MMCC brought us together for what we hope is a long, successful relationship with AmeriCann providing them our construction management services. The MMCC will establish a prototype for best-in-class cultivation facilities that we will replicate with AmeriCann as a design-build service throughout the country," stated Campanelli partner Rob DeMarco.
Massachusetts voters approved a ballot measure on November 8, 2016 that will make it the first state in the eastern U.S. to legalize the recreational use of marijuana. On December 15, 2016 the ballot initiative became law and recreational marijuana is now legal in Massachusetts.
The regulated cannabis industry is expected is to be one of the fastest growing industries in the country. The respected Wall Street firm of Cowen & Co recently released a research report projecting dramatic growth for the industry from the current $7 billion nationally to over $50 billion in ten years.
About AmeriCann
AmeriCann is a publicly traded company that plans to develop and lease sustainable, state-of-the-art medical cannabis cultivation properties. The Company has over 1,000,000 square feet of facilities in the planning and design stages of development. The Company has designed a proprietary line of cannabis infused products which will be branded and licensed to companies in regulated markets.
AmeriCann, Inc. is a Certified B Corp, an acknowledgment of the company's commitment to social and environmental ethics, transparency and accountability. AmeriCann became the first public cannabis company to earn this respected accreditation. More information about the Company is available at: www.americann.co.
About Massachusetts Medical Cannabis Center
The Massachusetts Medical Cannabis Center is approved for nearly 1,000,000 square feet of medical cannabis cultivation and processing in Freetown, Massachusetts. The state-of-the-art, sustainable, greenhouse project will consist of multiple planned phases for tenants in the Massachusetts medical marijuana market. AmeriCann's Cannopy System uniquely combines expertise from traditional horticulture, lean manufacturing, regulatory compliance and cannabis cultivation to create superior facilities and procedures.
The first phase potential of the project consists of a 160,000 square feet of cultivation and processing infrastructure. AmeriCann can expand the first phase based on patient demand without any disruption to the ongoing operations.
In October, AmeriCann completed the acquisition of the 53-acre Massachusetts property from Boston Beer Company (SAM-NYSE) for $4,475,000 cash.
About Campanelli
Established in 1947, Campanelli is a third generation, full-service commercial real estate development and acquisition company with extensive experience in the industrial, office, medical office, warehouse/distribution, retail, educational and cold storage markets. Campanelli began building homes during WWII and transitioned from residential to commercial real estate in the 1960's. The team, known for their seamless ability to work with their clients and act as the "real estate division" of a company, has developed 11 business parks in Massachusetts, over 20 million square feet across the nation and provided international development consulting and site selection services. The company's signature capabilities include land development, design and build, redevelopment and value-added acquisitions. It is Campanelli's all-encompassing and quality services that have led to its successful track record as a highly-regarded developer; from site selection, feasibility analysis, local, state and federal permitting, to architectural, engineering, design, building construction and property management. For more information, visit our new website at Campanelli.com.
AmeriCann is not going to have a problem getting their first phase at their massive Massachusetts Medical Cannabis Center (MMCC)
financed. It's one of if not the best deal in the cannabis industry.
http://americann.co/
Fully built out it will be the largest cannabis cultivation facility in the world (A similar 800,000 SF facility is being built in Canada by Aurora Cannabis (aurora cannabis.com) but MMCC will be 25% bigger and located 47 miles from Boston.(And by the way Aurora (ACBFF ) trades with a $350 million market cap)
ACAN spent two years and $1.5 million getting this thing all put together and ready for construction (environmental alone took six months) the ACAN CEO has a strong development background and Campanelli one of the big old line developers in Boston is going to be the turnkey builder.
Now with adult use cannabis official in Massachusetts the market there is heading to $1 billion a year by three years.
This MMCC project is extremely valuable to ACAN and while cannabis financing was hard to get a year ago it's plentiful now.
These guys will get this project financed and when they just announce the financing on the first phase this stock will soar.
It's trading at a $20 million market cap while 40 others with far less trade at over $100 mil.
This is the most overlooked, misunderstood and underrated stock in the sector. ACAN could have a real interesting 2017.
If the Dems had won the Whitehouse a month ago ACAN would be trading at levels far higher than it is.
The Sessions AG thing spooked the canna markets (except for Canada where MJ stocks are soaring)and investors put the foot on the brakes a little.
But ACAN has the biggest and best project in the cannabis industry in their mega Mass greenhouse campus.
And Trump Isn't going to get rid of one if the fastest growing and job creating new industries in the nation.(21,000 MJ jobs in Colorado alone).
The stock is worth more than its trading for even without the big Mass development. If they get it built the value to the shareholders will be enormous.
These guys are in the exact right place at the exact right time in Massachusetts. Their project will be highly profitable with just medical MJ and full adult legality just passed there-a $1 billion a year market just getting started.
ACAN is the best value play in the cannabis sector and the market will soon figure that out.
There are dozens of crappy public cannabis companies that just issue press releases and don't do anything but still trade at over $50 or even $100 million value while ACAN is far more valuable and trades at a valuation of only $20 million.
The REIT IPO Innovative Industrial Property raised $60 mil today and got listed on the NYSE.
This was really good for them, and the credibility of the cannabis industry and shows how dynamic the cannabis real estate sector is becoming.
The industry will Need an estimated 200 million SF of greenhouses over the next five years and this a exactly what ACAN specializes in.
These guys are two years ahead in Massachusetts and it's becoming the hottest state for cannabis development in the nation for 2017- and everyone in the industry knows it. 1 million SF all approved and ready to build 47 miles from Boston.
This stock could get very interesting and soon.
The financials for ACAN are good with nice cash to work with from a recent private equity placement by broker/dealers.
And their Mass project is potentially a really big deal-it could become
the biggest cannabis production facility in the world 47 miles from Boston in the midst of what looks like a red hot Massachusetts cannabis market--for many years--with estimated annual revenue of over $1 billion and very little cannabis infrastructure in place
But by far the biggest asset of ACAN is their top management team and the knowledge they have developed over the past four years on the front end of the cannabis industry as it has grown and developed.
Ask anyone in the cannabis industry about the AmeriCann CEO Tim Keogh and they'll probably tell you he's one of the most respected leaders in this space.
This company has the usual risk that goes with all public cannabis companies-but the upside potential here if they execute their ambitious plans is real exciting in my opinion.
I've watched AmeriCann and owned the stock since its first capital raise at $.75 in early 2014. (Americann.co)
Everyone focuses on ACAN's
Massachusetts cultivation center and that's justified given the huge size, (25 football fields in size when all built out) the appeal of the Massachusetts market and the potential impact to the company.
But this is also -beyond Massachusetts-a company with a very serious management team that was an early entrant into the cannabis industry in Colorado. They have $2 million invested in land they own in Colorado and $1 million in an Illinois cultivation center. They invested $1 million in a cultivation operation in Colorado in 2014 and have gotten all their investment back plus $300,000 more.
This is all in their public filings.
Management has put up over $5 million of their own capital in building the business and ACAN completed a broker dealer led $2 million equity raise just before the election so they have a nice cash position. (Unlike most cannabis companies).
They have spent over $1.4 million and two years getting the giant MMCC proposed project zoned and approved and that looks real smart now. Massachusetts is going to need millions of square feet of cultivation capacity.
ACAN has a well structured capitalization with under 20 million shares outstanding and no cheap options or toxic debt.
And their market value is under $30 million while many clearly inferior public companies have much higher valuations.
Do your own research and DD and you'll see why people that know the industry like this company and what they are doing.
They have very ambitious long term national plans and if they succeed the shareholders will be very well rewarded.
CNBC special report on how cannabis real estate is the hottest part of the cannabis market.. ACAN is the biggest and the leader in that sector.
http://www.cnbc.com/2016/10/25/how-pot-is-firing-up-this-real-estate.html
Time to load shares. IMO... $ACAN
Terrific news out on ACAN today :)
AmeriCann To Benefit from Positive Cannabis Election Results
Accesswire AccesswireNovember 14, 2016Comment
Company Plans to Accelerate the Development of its Approved 1,000,000 Square Foot Cultivation Project in Massachusetts; Regulation in Additional States Provides New Opportunities for Expansion
DENVER, CO / ACCESSWIRE / November 14, 2016 / AmeriCann, Inc. (ACAN), a company that plans to develop sustainable, state-of-the-art medical cannabis cultivation properties, intends to accelerate the development schedule for its Massachusetts Medical Cannabis Center project and expansion plans for new markets in response to recent election results.
Massachusetts voters approved a ballot measure that will make it the first state in the eastern U.S. to legalize the recreational use of marijuana. The Commonwealth has had a medical marijuana program that was approved in 2012. According to industry experts, the combined market for both the medical and new adult program could exceed $1.8 billion annually.
Company CEO Tim Keogh stated, "The legalization of cannabis for all adults in Massachusetts significantly expands the need for the infrastructure to serve both patients and consumers. With nearly 1,000,000 square feet approved for development, AmeriCann can provide the type of sustainable, energy efficient cultivation facilities that is essential to serve the citizens of Massachusetts."
AmeriCann recently completed the acquisition of a 53 acre Massachusetts property from Boston Beer Company (SAM-NYSE) for $4,475,000 cash. The Company plans to develop the property as the Massachusetts Medical Cannabis Center (the "MMCC"), which is expected to be one of the largest and most technologically advanced cannabis cultivation facilities in the nation.
The MMCC is approved for nearly 1,000,000 square feet of medical cannabis cultivation and processing in Freetown, Massachusetts. The state-of-the-art, sustainable, greenhouse project will consist of multiple planned phases for tenants in the Massachusetts medical marijuana market. AmeriCann's engineering team is in the process of finalizing documents for construction. The Company expects to break ground in the first quarter of 2017 and have cannabis in production by fall of 2017.
AmeriCann recently completed a $2 million all equity financing that will be utilized in part for the Company's Massachusetts Medical Cannabis Center development and to pursue new opportunities in California, Pennsylvania, Florida and other states.
With three national surveys this year showing 60 percent or greater support for cannabis legalization, many experts believe that public attitudes have reached a tipping point. This belief was reinforced with overwhelming voter support for legalization in elections last week.
Massachusetts, California, Maine, and Nevada voted to legalize recreational marijuana while Arkansas and North Dakota approved medical cannabis initiatives. Florida voters approved medical marijuana in a landslide with over 71% of the vote. With these election results, medical cannabis is now legal in a majority of the country with 28 states sanctioning the production and sale of cannabis.
The respected Wall Street firm of Cowen & Co recently released a research report projecting dramatic growth for the regulated cannabis industry from the current $7 billion nationally to over $50 billion in ten years.
About AmeriCann
AmeriCann is a publicly traded company that plans to develop and lease sustainable, state-of-the-art medical cannabis cultivation properties. The Company has over 1,000,000 square feet of facilities in the planning and design stages of development. The Company has designed a proprietary line of cannabis infused products which will be branded and licensed to companies in regulated markets.
AmeriCann, Inc. is a Certified B Corp, an acknowledgment of the company's commitment to social and environmental ethics, transparency and accountability. AmeriCann became the first public cannabis company to earn this respected accreditation. More information about the Company is available at: www.americann.co.
About Massachusetts Medical Cannabis Center
The Massachusetts Medical Cannabis Center is approved for nearly 1,000,000 square feet of medical cannabis cultivation and processing in Freetown, Massachusetts. The state-of-the-art, sustainable, greenhouse project will consist of multiple planned phases for tenants in the Massachusetts medical marijuana market. AmeriCann’s Cannopy System uniquely combines expertise from traditional horticulture, lean manufacturing, regulatory compliance and cannabis cultivation to create superior facilities and procedures.
The first phase of the project consists of 130,000 sq. ft. of cultivation and processing infrastructure. AmeriCann can expand the first phase to approximately 600,000 sq. ft., based on patient demand.
The fully built out ACAN plant south of Boston will be the size of 25 football fields of greenhouses and have the capacity to produce $1 billion of cannabis a year--Whether they lease, sell or operate the plant it will be highly valuable to a small cap public company.
It takes many months or even years to get a large scale cannabis project like this approved in Massachusetts and this company has a major two year head start.
ACAN trades with a market capitalization of under $30 million while dozens of other cannabis stocks trade for values of $200 million to $1 billion.
ACAN bet a lot on the future of the Massachusetts cannabis market and it looks like a great bet.
Marijuana King at the Ballot Box
http://us10.campaign-archive2.com/?u=e779e5d3e9069a662ece76264&id=d4f2ace7ae&e=4ec5cdd6da
Exciting times for ACAN. My favorite stock play by far.
http://www.cannabisbusinesstimes.com/article/110916-massachusetts-cannabis-election-2016/
AmeriCann Inc (OTCMKTS:ACAN) has been one of the top performing cannabis stocks of 2016. ACAN had been quiet for most of 2016 and then exploded in October as investors get set for Green Rush 2.0 just around the corner. Come election day, voters in at least nine states will decide on whether to legalize either the recreational use or the medical use of marijuana. As it stands now, those states include Arizona, Arkansas, California, Florida, Maine, Massachusetts, Montana, Nevada and North Dakota.
So far, 25 states have established medical marijuana programs. These states include: Alaska, Arizona, California, Colorado, Connecticut, Delaware, Hawaii, Illinois, Maine,Maryland, Massachusetts, Michigan, Minnesota, Montana, Nevada, New Hampshire, New Jersey, New Mexico, New York, Ohio, Oregon, Pennsylvania, Rhode Island,Vermont, and Washington. In addition, Washington, DC and Puerto Rico allow medical marijuana for patients.
Additional states, while not offering comprehensive medical marijuana programs, have approved marijuana-based “low THC, high cannabidiol (CBD)” products for limited medical purposes. These states include Alabama, Florida, Georgia, Iowa, Kentucky, Louisiana, Mississippi, Missouri, North Carolina, Oklahoma, South Carolina,Tennessee, Texas, Utah, Virginia, Wisconsin, and Wyoming.
Alternatively, CBD oil products that are derived from hemp are legal to purchase and use in all 50 states without a visit to a doctor, a medical marijuana card, or paying a state enrollment fee. Made with naturally high-CBD, low-THC hemp, these products contain the same levels of CBD as those sold in medical marijuana dispensaries, but because they are sold as supplements, they are 100% legal in the U.S.
AmeriCann Inc plans to develop and lease sustainable, state-of-the-art medical cannabis cultivation properties. The Company has over 1,000,000 square feet of facilities in the planning and design stages of development. The Company has designed a proprietary line of cannabis infused products which will be branded and licensed to companies in regulated markets.
Americann Inc just completed its acquisition of a nearly 53-acre property from Boston Beer Company (NYSE:SAM) for $4,475,000. The Company plans to develop the property as the Massachusetts Medical Cannabis Center (the “MMCC”), one of the largest and most technologically advanced cannabis cultivation facilities in the nation.
Designs for the MMCC include the construction of sustainable greenhouse cultivation, processing, and infused product facilities that will be leased or sold to Registered Marijuana Dispensaries under the Massachusetts Medical Marijuana Program. The Company has received unanimous approval from the Town of Freetown Planning Board for the development of 977,000 square feet of cannabis cultivation and processing infrastructure on the property. In addition, AmeriCann has signed definitive agreements with a provisionally licensed organization to become the initial tenant in the planned MMCC.
When fully developed, the MMCC is projected to create over 300 jobs with an annual projected payroll of over $14 million to the local community. Construction is expected to commence in early 2017 with first cannabis produced by late 2017. AmeriCann and Freetown officials have been engaged in the approval process for over a year and the town has provided strong support for the MMCC. The Freetown planning board gave unanimous approval to the development plans in a public forum. Planning Board Chairman Kevin Desmarais closed the meeting by saying, “This has been one of the better public processes with which I’ve been involved.”
In September, AmeriCann launched Solanna, a new comprehensive line of nutraceutical-grade cannabis infused products. The Company plans to expand the product line to include edible products, health drinks, and branded concentrates. The products are designed to allow consumers to manage dosage through micro-dosing and to improve efficacy by incorporating blends of other plants, essential oils and other supplements that enhance and compliment the benefits of cannabis.
Currently trading with a market cap of $46 million, ACAN keeps running up the charts. There are 16.6 million shares outstanding, of which just 5.4 million is in the float. While other cannabis names are fighting for market share in California, Colorado, Nevada, Washington and Oregon, ACAN has focused and positioned itself better than any other cannabis company in Massachusetts. This makes ACAN certainly one name that needs to be on every pot stock investor’s radar.
I think ACAN breaks $4 this week. IMO
AmeriCann (ACAN) is already in a great position with their giant Massachusetts greenhouse project all approved and ready to build to serve the robust medical market there. (AmeriCann.co)
If "Question 4" allowing for adult use in Mass passes next week as is expected experts project a $7 billion market there by 2021.
If Mass does go full legal Nov. 8 ACAN will immediately become a power in the cannabis industry and attract a lot more attention from investors.
This is a very solid company with an extremely solid and talented management team. ACAN will get the financing for the development of phase 1.. IMO this stock is a steal at this price. When it runs I think it will be a very exciting ride for everyone that jumped in early.
This is going to be an exciting ride. Hold on tight. Let's go ACAN.
ACAN--$5 by the election, $10 if Mass approves full adult use, $20 by year end. IMO... very exciting.
A long time in the making, now ACAN is off and running. 2017 should be a fantastic year…
AmeriCann Completes Land Purchase for Development of Large-Scale Massachusetts Cannabis Production Center
Accesswire October 26, 2016Comment
Company Acquires Property from Boston Beer Company, Maker of Sam Adams Beer, for $4,475,000; Expects to Begin Construction in Early 2017 and Commence Operations by the End of 2017
DENVER, CO / ACCESSWIRE / October 26, 2016 / AmeriCann, Inc. (ACAN), a company that plans to develop sustainable, state-of-the-art medical cannabis cultivation properties, has completed its acquisition of a nearly 53-acre property from Boston Beer Company (NYSE:SAM) for $4,475,000.
The Company plans to develop the property as the Massachusetts Medical Cannabis Center (the "MMCC"), one of the largest and most technologically advanced cannabis cultivation facilities in the nation.
MMCC Rendering:
Designs for the MMCC include the construction of sustainable greenhouse cultivation, processing, and infused product facilities that will be leased or sold to Registered Marijuana Dispensaries under the Massachusetts Medical Marijuana Program.
The Company has received unanimous approval from the Town of Freetown Planning Board for the development of 977,000 square feet of cannabis cultivation and processing infrastructure on the property. In addition, AmeriCann has signed definitive agreements with a provisionally licensed organization to become the initial tenant in the planned MMCC.
As part of the closing transaction, AmeriCann transferred the property to a real estate investment group, Massachusetts Medical Properties, LLC and entered into a 50-year lease with options to extend for an additional 40 years. The sale-leaseback transaction allows AmeriCann to focus on raising capital to build revenue-generating infrastructure on the property.
When fully developed, the MMCC is projected to create over 300 jobs with an annual projected payroll of over $14 million to the local community. Construction is expected to commence in early 2017 with first cannabis produced by late 2017.
AmeriCann and Freetown officials have been engaged in the approval process for over a year and the town has provided strong support for the MMCC. The Freetown planning board gave unanimous approval to the development plans in a public forum. Planning Board Chairman Kevin Desmarais closed the meeting by saying, "This has been one of the better public processes with which I've been involved."
Twenty-five states and the District of Columbia have regulated the use of cannabis. Additionally, nine states with over 30% of the United States population will be voting on November 8th regulating the sale of cannabis for medicinal or recreational use. Most ballot measures favoring cannabis are polling favorably.
The respected Wall Street firm of Cowen & Co recently released a research report projecting dramatic growth for the regulated cannabis industry from the current $7 billion nationally to over $50 billion in ten years.
The Massachusetts Medical Use of Marijuana Program, which was approved by voters in 2012 by a wide margin, continues to be one of the highest regarded medical cannabis programs in the nation by industry experts even with the first dispensaries having only recently opened. The first phase plans for MMCC are based on demand from the existing medical market. AmeriCann will monitor the vote in Massachusetts on adult use and may modify the planned capacity accordingly.
"The state [Massachusetts] could become one of the biggest regulated cannabis markets in the country; bigger than Colorado and Washington State," according to Marijuana Business Daily. The Boston Globe recently reported the regulated cannabis market in Massachusetts may exceed $1 billion by 2020.
"There is a lack of existing and planned cultivation infrastructure in the Massachusetts market which creates the opportunity for developing MMCC," stated Tim Keogh, CEO of AmeriCann. He went on to say, "in addition, the size of the project, as well as the design of the facility using our Cannopy System, will produce sun-grown cannabis in a more cost effective manner than traditional indoor facilities creating a significant competitive advantage."
The Boston Globe, in reporting on the Freetown property acquisition stated, "Advocates have repeatedly complained that Massachusetts has too few medical marijuana dispensaries and growing facilities, and the legal marijuana available is too expensive - problems Keogh hopes the Freetown complex will help solve."
According to Matt Karnes, Founder and Managing Partner of the respected NY-based cannabis industry research firm GreenWave Advisors, "We believe that the future of the cannabis industry is large-scale, energy efficient greenhouse cultivation and processing. AmeriCann is well positioned at the forefront of this development."
About AmeriCann
AmeriCann is a publicly traded company that plans to develop and lease sustainable, state-of-the-art medical cannabis cultivation properties. The Company has over 1,000,000 square feet of facilities in the planning and design stages of development. The Company has designed a proprietary line of cannabis infused products which will be branded and licensed to companies in regulated markets.
AmeriCann, Inc. is a Certified B Corp, an acknowledgment of the company's commitment to social and environmental ethics, transparency and accountability. AmeriCann became the first public cannabis company to earn this respected accreditation. More information about the Company is available at: www.americann.co.
About Massachusetts Medical Cannabis Center
The Massachusetts Medical Cannabis Center is approved for nearly 1,000,000 square feet of medical cannabis cultivation and processing in Freetown, Massachusetts. The state-of-the-art, sustainable, greenhouse project will consist of multiple planned phases for tenants in the Massachusetts medical marijuana market. AmeriCann's Cannopy System uniquely combines expertise from traditional horticulture, lean manufacturing, regulatory compliance and cannabis cultivation to create superior facilities and procedures.
The first phase of the project consists of 130,000 sq. ft. of cultivation and processing infrastructure. AmeriCann can expand the first phase to approximately 600,000 sq. ft., based on patient demand.
This is going to be a fun ride.
Since there is so much discussion about the AmeriCann land purchase from Boston Beer last week I thought I'd contribute this analysis--as I believe I understand the deal.( I'm a shareholder and have followed the company closely since early 2014.)
MMP-the group that put up the $3,550,000 (ACAN also contributed $925,000 cash) to close on the land from Boston beer for $4,575,009 is actually not ACAN management-it is a new LLC recently formed by very wealthy real estate investor who is the uncle of Ben Barton.
Ben is the ACAN founder and largest shareholder. (Who was also a founder and large shareholder in a highly successful Denver based startup-Synergy Resources (SYRG-NYSE) that has a market value of $1.5 billion.)
Ben has contributed almost $5,000,000 of his own cash in the building of AmeriCann to date but this latest traunch came from his rich uncle who also got shares and warrants(at $1.00) in ACAN.
In exchange ACAN got a 90 year exclusive land lease to develop the Boston beer property with no cash or release price required.
And ACAN got to book the $925,000 as a balance sheet asset. This lease will make the building of the project much easier. (See recent 8-K)
But If ACAN owns or has a long term land lease here is not the major issue.
What is the major issue is the land is approved ( after two years of work by the ACAN CEO ) for 1 mil SF.of cannabis cultivation-24 football fields-a commodity that is in short supply in Mass-
a fast emerging cannabis state in a very hot industry. Classic right time-right place and with a wealthy and friendly financial partner in place.
And in two weeks ( Nov. 8) Mass voters will likely approve full adult use legal cannabis-(with an estimated $2.7 bil annual market) and if they do-(85% on betting lines) the 52 acres will be very valuable and ACAN stock should attract a lot of attention. Their upside is enormous.
Hope this helps.
I'm biased so do your own research but I really like this company and the stock.
See AmeriCann.co for more information.
Since there is so much discussion about the AmeriCann land purchase from Boston Beer last week I thought I'd contribute this analysis--as I believe I understand the deal.( I'm a shareholder and have followed the company closely since early 2014.)
MMP-the group that put up the $3,550,000 (ACAN also contributed $925,000 cash) to close on the land from Boston beer for $4,575,009 is actually not ACAN management-it is a new LLC recently formed by very wealthy real estate investor who is the uncle of Ben Barton.
Ben is the ACAN founder and largest shareholder. (Who was also a founder and large shareholder in a highly successful Denver based startup-Synergy Resources (SYRG-NYSE) that has a market value of $1.5 billion.)
Ben has contributed almost $5,000,000 of his own cash in the building of AmeriCann to date but this latest traunch came from his rich uncle who also got shares and warrants(at $1.00) in ACAN.
In exchange ACAN got a 90 year exclusive land lease to develop the Boston beer property with no cash or release price required.
And ACAN got to book the $925,000 as a balance sheet asset. This lease will make the building of the project much easier. (See recent 8-K)
But If ACAN owns or has a long term land lease here is not the major issue.
What is the major issue is the land is approved ( after two years of work by the ACAN CEO ) for 1 mil SF.of cannabis cultivation-24 football fields-a commodity that is in short supply in Mass-a fast emerging cannabis state in a very hot industry. Classic right time-right place and with a wealthy and friendly financial partner in place.
And in two weeks ( Nov. 8) Mass voters will likely approve full adult use legal cannabis-(with an estimated $2.7 bil annual market) and if they do-(85% on betting lines) the 52 acres will be very valuable and ACAN stock should attract a lot of attention. Their upside is enormous.
Hope this helps.
I'm biased so do your own research but I really like this company and the stock.
See AmeriCann.co for more information.
What's Alan going to say when this stock runs and breaks $10? Oops
Nice volume today ACAN. Great time to load up on shares. IMO..
This is a huge accomplishment for ACAN. Amazing news, and nice volume today. This is one of my favorite cannabis plays hands down. Time to sit back and enjoy the ride.
This company continues to do everything right. I strongly believe that Shareholders will benefit big time when it all comes together ... IMO..
Very nice update ACAN, this is one of my favorite cannabis plays.
http://finance.yahoo.com/news/americann-earns-prestigious-b-corp-123000901.html;_ylc=X1MDMTE5Nzc4NDE4NQRfZXgDMQRfeXJpZAM4ZnRncTNoYm1wa2IyBGcDZFhWcFpEeHVjejVsWlRBMVpUQmpZeTFqTW1VMUxUTTJOV1V0WVdGa055MWhNV1F4TlRVMk1tTmpOemc4Wm1sbGJHUStZV05oYmc9PQRsYW5nA2VuLVVTBG9yaWdfbGFuZwNlbgRvcmlnX3JlZ2lvbgNVUwRwb3MDMARyZWdpb24DVVMEc3ltYm9sA0FDQU4-?.tsrc=applewf
The more I read about ACAN the more it impresses me... Should be a fun ride.